News

Published on 23 Apr 2024 on Simply Wall St. via Yahoo Finance

Illumina (NASDAQ:ILMN) investors are sitting on a loss of 71% if they invested three years ago


Article preview image

As every investor would know, not every swing hits the sweet spot. But you have a problem if you face massive losses more than once in a while. So spare a thought for the long term shareholders of Illumina, Inc. (NASDAQ:ILMN); the share price is down a whopping 71% in the last three years. That might cause some serious doubts about the merits of the initial decision to buy the stock, to put it mildly. And the ride hasn't got any smoother in recent times over the last year, with the price 45% lower in that time. The falls have accelerated recently, with the share price down 15% in the last three months.

Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.

NASDAQ.ILMN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Biotech giant lays groundwork for divestiture of early-cancer test maker Grail - San Francisco...

Illumina Inc. hopes to finalize terms by the end of June for the divestment of its Grail LLC unit...

The Business Journals 7 May 2024

Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens

Illumina Inc. ILMN reported first-quarter 2024 adjusted earnings per share (EPS) of 9 cents, whic...

Zacks via Yahoo Finance 4 May 2024

Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript

Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript May 2, 2024 Illumina, Inc. misses o...

Insider Monkey via Yahoo Finance 4 May 2024

...Will Non-Farm Payrolls Data Play Spoilsport? - Invesco QQQ Trust, Series 1 (NASDAQ:QQQ), SPDR S&P...

Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although...

Benzinga 3 May 2024

Earnings call: Illumina Q1 2024 results show resilience amid challenges By Investing.com

Illumina, Inc. (NASDAQ:ILMN), a global leader in genomics, reported its first-quarter financial...

Investing.com 3 May 2024

Will These 5 MedTech Stocks Beat Forecasts This Earnings Season?

We are in the middle of the first-quarter 2024 earnings season, with numerous MedTech bigwigs hav...

Zacks via Yahoo Finance 1 May 2024

Jim Cramer Rejects Illumina As 'It's Not Well-Run,' Recommends Buying This Tech Stock 'Right Here,...

On CNBC's Mad Money Lightning Round,” Jim Cramer said Dynatrace, Inc. DT is “very expensive” stoc...

Benzinga 30 Apr 2024

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1...

Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. ...

Benzinga 29 Apr 2024

Microsoft-Backed Rubrik Exceeds IPO Goal to Raise $752 Million

(Bloomberg) -- Rubrik Inc., a cloud and data security startup backed by Microsoft Corp., priced i...

Bloomberg via Yahoo Finance 25 Apr 2024

Illumina (NASDAQ:ILMN) investors are sitting on a loss of 71% if they invested three years ago

As every investor would know, not every swing hits the sweet spot. But you have a problem if you ...

Simply Wall St. via Yahoo Finance 23 Apr 2024